Solitron Devices, Inc. filings document operating results, bookings disclosures and governance matters for a manufacturer of solid state semiconductor components and related devices serving military and aerospace markets. Current reports on Form 8-K furnish press releases on fiscal results, bookings, backlog, Regulation FD disclosures, and material events connected to the company’s operations.
Proxy materials cover annual-meeting matters including Class III director elections, auditor ratification and advisory votes on executive compensation. The filing record also reflects disclosure topics tied to the Micro Engineering Inc. acquisition, including integration-related reporting, acquisition accounting, contingent consideration, capital-structure disclosures and board governance.
Solitron Devices, Inc. reported fiscal 2027 second-quarter revenue of $5.657 million, compared with $5.44 million in the first quarter and $3.986 million in the year-earlier quarter; the company attributed the increase to its strong backlog. Net income was $1.298 million, versus a net loss of $234,000 in the year-earlier quarter. For the six months ended August 31, 2026, net sales were $11.093 million and net income was $2.288 million, compared with $6.686 million in sales and a $570,000 net loss a year earlier.
Backlog remained at record levels, reaching $24.11 million at the end of the quarter, compared with $23.34 million at fiscal 2027 first-quarter end. Net income included $200,000 in professional fees recorded in SG&A for an investment banker retained to assist with exploring strategic alternatives. The company expects sales to remain at this level or greater for the rest of fiscal 2027 and currently expects the next AMRAAM order in fiscal fourth quarter. Potential multi-year orders for AMRAAM and Standard Missiles 2, 3 and 6 remain subject to Congressional funding.
Solitron said no actual income taxes were due because it has deferred tax assets related to previous net operating losses.
Solitron Devices Inc. (SODI) reported net sales of $5.657 million for the three months ended August 31, 2026, up 42% from $3.986 million a year earlier. Net income was $1.298 million, compared with a $234,000 net loss. Gross profit was $2.748 million, versus $835,000.
For the six months ended August 31, 2026, sales were $11.093 million, up 66% from $6.686 million, and net income was $2.288 million versus a $570,000 net loss. Operating cash flow was $3.601 million, compared with $777,000. Backlog was $24.112 million as of August 31, 2026, versus $18.642 million one year earlier; management attributed the increase primarily to a large MEI order received during the quarter. Cash and cash equivalents were $7.357 million as of August 31, 2026.
RTX, ConMed Linvatec and L3 Harris accounted for 74% of six-month sales. Management said disclosure controls were appropriately designed, but there was insufficient evidence to test whether they operated effectively as of August 31, 2026, to remediate a previously reported material weakness. The company recorded $200,000 of professional fees related to pursuing strategic alternatives.
Olesen Value Fund L.P., a ten-percent owner of Solitron Devices Inc. (SODI), reported sales of shares directly beneficially owned by the Fund: 4,800 shares at $33.17 per share on September 30, 2026, and 600 shares at $33.25 per share on September 29, 2026. The Fund’s general partner, Olesen Value Fund GP LLC, its investment manager, Olesen Capital Management LLC, and Christian Olesen, managing member of both, also reported deemed beneficial ownership of those shares. No Rule 10b5-1 plan is reported.
Solitron Devices Inc. received notice that Olesen Value Fund L.P., identified as a 10% stockholder, intends to sell up to 20,000 common shares through broker(s) listed, including Auerbach Grayson & Company LLC. The shares are owned by the fund and controlled by Olesen Value Fund GP LLC as general partner, Olesen Capital Management LLC as investment manager, and Christian Olesen, managing member of both LLCs. Securities information lists an aggregate market value of $665,800.00 and 2,152,703 shares outstanding.
SOLITRON DEVICES INC (SODI) reported that President and COO Mark Matson completed an "other" acquisition of 3,000 shares of common stock on September 10, 2026, increasing his direct holdings to 241,573 shares. The transaction was executed under a Rule 10b5-1(c) trading plan and his Employment Agreement, which permits quarterly purchases at a weighted average price.
SOLITRON DEVICES INC (SODI) insider reporting involves a sale of common stock by investment entities associated with CEO and 10% owner Howard Timothy Eriksen. On 2026-08-13, entities advised by Eriksen Capital Management LLC sold 500 shares of common stock at $34.70 per share, held indirectly for clients, leaving 271,333 shares reported as indirectly owned. A separate line reports 60,827 shares held directly. The sale is described as part of client portfolio rebalancing and tax planning, with Mr. Eriksen disclaiming beneficial ownership beyond his pecuniary interest.
Solitron Devices Inc. insider-related entities reported a net purchase of common stock. On 2026-08-14, Allens Creek Partners LP purchased 8,000 shares of Solitron common stock at $28.50 per share in a private agreement with Mr. Chiste; the price was agreed before the purchase date and later price changes, and the shares remain subject to an affiliate restriction. After this transaction, entities associated with Eriksen Capital Management LLC (managed by CEO Tim Eriksen) reported 271,833 shares held indirectly and 60,827 shares held directly, with footnotes stating that beneficial ownership is disclaimed except to the extent of pecuniary interest and that voting for certain managed accounts rests with the account owners.
Solitron Devices Inc. director John F. Chiste reported a sale of 8,000 shares of common stock on 2026-08-14 at $28.50 per share in a private agreement with Allens Creek Partners LP. The transaction reduced his directly held common stock position to zero shares, and the shares retain an affiliate restriction after the sale.
Solitron Devices Inc. insider reporting relates to CEO and 10% owner Howard Timothy Eriksen and affiliated entities Eriksen Capital Management LLC (ECM) and Cedar Creek Partners LLC. An investment partnership and ECM-managed accounts sold 563 shares of Solitron Devices common stock on 2026-08-11 at $34.82 per share in a transaction reported as an indirect sale. After this sale, affiliated indirect holdings total 263,833 shares, consisting of 240,341 shares held by Cedar Creek Partners LLC and 23,492 shares held in ECM-managed accounts, where the respective account owners vote the shares. Howard Eriksen also holds 60,827 shares directly. The filing states that the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest and that the 563-share sale was part of client portfolio rebalancing and tax planning.
Olesen Value Fund L.P., a more-than-10% owner of Solitron Devices, reported selling 1,488 shares of common stock on July 22, 2026 at $29.84 per share. After these sales, the filing reports 216,508 shares of common stock beneficially owned. Related entities Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen may be deemed beneficial owners of the fund’s shares, and each disclaims beneficial ownership beyond its or his pecuniary interest.